Status:
COMPLETED
Validity and Reliability of the PROprioception Measurement Tool (PROMT)
Lead Sponsor:
University Children's Hospital, Zurich
Collaborating Sponsors:
Queen Margaret University
Conditions:
Child Development
Upper Motor Neurone Lesion
Eligibility:
All Genders
5-19 years
Phase:
NA
Brief Summary
This project assesses the feasibility, reliability, and validity of the PROMT in children with a UMN lesion. The study questions are: is the newly developed PROMT a feasible, reliable, and valid tool ...
Detailed Description
Somatosensory function is essential to all our movements and activities. This is also the case for children with Upper Motor Neuron (UMN) lesions, such as cerebral palsy or acquired brain lesions. Esp...
Eligibility Criteria
Inclusion
- neuromotor impairments due to UMN lesions (diagnoses can be, for example, cerebral palsy (CP), acquired brain injuries, myelomeningocele, hydrocephalus)
- ability to sit with or without back support for 30 minutes
- ability to stand with or without support
- ability to do some steps
- informed consent.
Exclusion
- severe visual impairment
- surgery within the last six months with involvement of the lower limbs
- botulinum toxin injection in the lower limbs within the previous three months
- unable to communicate pain or discomfort (verbally or nonverbally)
- noncompliance
- not able to follow simple short instructions
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2023
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT05405881
Start Date
October 1 2022
End Date
August 30 2023
Last Update
December 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Swiss Children's Rehab
Affoltern am Albis, Canton of Zurich, Switzerland, 8910